Advertisement
Screener

CytomX Therapeutics, Inc. (CTMX) Other

CytomX Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-16: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market.
  • 2026-03-16: Form 10-K; Item Smaller reporting company; As filed Yes.
  • 2025-11-06: Form 10-Q; Item Smaller reporting company; As filed Yes.
  • 2025-08-07: Form 10-Q; Item Smaller reporting company; As filed Yes.
FiledFormItemAs filed
2026-03-1610-KStock registered under Section 12(b)Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market
2026-03-1610-KSmaller reporting companyYes
2025-11-0610-QSmaller reporting companyYes
2025-08-0710-QSmaller reporting companyYes
2025-05-1210-QSmaller reporting companyYes
2025-03-0610-KStock registered under Section 12(b)Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market
2025-03-0610-KSmaller reporting companyYes
2025-03-0610-KWell-known seasoned issuerNo
2024-11-0710-QSmaller reporting companyYes
2024-08-0810-QSmaller reporting companyYes
2024-05-0810-QSmaller reporting companyYes
2024-03-1110-KStock registered under Section 12(b)Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market
2024-03-1110-KSmaller reporting companyYes
2024-03-1110-KWell-known seasoned issuerNo
2023-11-0710-QSmaller reporting companyYes
2023-08-0810-QSmaller reporting companyYes
2023-05-0910-QSmaller reporting companyYes
2023-03-2710-KStock registered under Section 12(b)Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market
2023-03-2710-K/AStock registered under Section 12(b)Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market
2023-03-2710-KSmaller reporting companyYes
2023-03-2710-KWell-known seasoned issuerNo
2023-03-2710-K/AWell-known seasoned issuerNo
2022-03-0110-KStock registered under Section 12(b)Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market
2022-03-0110-KWell-known seasoned issuerNo
2021-08-0510-QStock registered under Section 12(b)Common Stock, $0.00001 par value per share · CTMX · Nasdaq Global Select Market
2021-05-0610-QStock registered under Section 12(b)Common Stock, $0.00001 par value per share · CTMX · Nasdaq Global Select Market
2021-02-2410-KStock registered under Section 12(b)Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market
2021-02-2410-KWell-known seasoned issuerNo
2020-11-0510-QStock registered under Section 12(b)Common Stock, $0.00001 par value per share · CTMX · Nasdaq Global Select Market
2020-08-0610-QStock registered under Section 12(b)Common Stock, $0.00001 par value per share · CTMX · Nasdaq Global Select Market
2020-05-0710-QStock registered under Section 12(b)Common Stock, $0.00001 par value per share · CTMX · Nasdaq Global Select Market
2020-02-2710-KStock registered under Section 12(b)Common Stock, $0.00001 par value · CTMX · The Nasdaq Global Select Market
2020-02-2710-KWell-known seasoned issuerNo
2019-11-0710-QStock registered under Section 12(b)Common Stock, $0.00001 par value per share · CTMX · Nasdaq Global Select Market
2019-02-2710-KWell-known seasoned issuerNo
2018-11-0610-QEmerging growth companyYes
2018-03-0710-KWell-known seasoned issuerNo
2017-03-0210-KWell-known seasoned issuerNo
2016-03-0710-KWell-known seasoned issuerNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B